Filtered By:
Procedure: PET Scan
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 37 results found since Jan 2013.

Cervical human papillomavirus prevalence according to socioeconomic and demographic characteristics in a large Danish screening population
CONCLUSIONS: We found slightly higher hrHPV prevalences in women with basic education, low income and unemployment. The differences largely disappeared when taking into account marital status as a potential proxy for sexual behaviour. Our findings support a need for targeted information on safe sexual practices and promoting socioeconomic equality in HPV vaccination and cervical cancer screening participation.PMID:37078420 | DOI:10.1177/14034948231168297
Source: Scandinavian Journal of Public Health - April 20, 2023 Category: International Medicine & Public Health Authors: Freja L Ærke Sand Louise T Thomsen Dorthe Oernskov Christian Munk Marianne Waldstroem Susanne K Kjaer Source Type: research

Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study
CONCLUSIONS: The incidence of PAGC has not increased over time perhaps reflecting, in part, the effectiveness of cervical screening and early impacts of human papillomavirus vaccination programs in Australia. The higher rate of preterm birth among the gestational PAGC group is associated with adverse outcomes in babies born to these women.PMID:36915236 | DOI:10.1111/aogs.14530
Source: Cancer Control - March 14, 2023 Category: Cancer & Oncology Authors: Penelope Fotheringham Nadom Safi Zhouyang Li Antoinette Anazodo Marc Remond Andrew Hayen David Currow David Roder Nada Hamad Michael Nicholl Adrienne Gordon Jane Frawley Elizabeth A Sullivan Source Type: research

Feasibility and acceptability of self-collection of Human Papillomavirus samples for primary cervical cancer screening on the Caribbean Coast of Nicaragua: A mixed-methods study
CONCLUSION: Self-collection of samples for hrHPV testing demonstrated high acceptability and feasibility. Through concerted effort at the local, regional, and national levels, this project supported capacity building in reporting, monitoring, and surveilling cervical cancer screening across the continuum of cervical cancer control.PMID:36741739 | PMC:PMC9895854 | DOI:10.3389/fonc.2022.1020205
Source: Cancer Control - February 6, 2023 Category: Cancer & Oncology Authors: Emma McKim Mitchell Katherine M Hall Aubrey Doede Anneda Rong Michelet McLean Estrada Orlando Benito Granera Francisco Maldonado Hala Al Kallas Cassandra Bravo-Rodriguez Mariana Forero Yolande Pokam Tchuisseu Rebecca A Dillingham Source Type: research

Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review
CONCLUSION: Knowledge and uptake of cervical cancer preventive services across diverse groups in Nigeria remain poor. These could be linked to socio-cultural factors, the lack of an organised cervical cancer screening programme and low financial resource pool for cervical cancer prevention. Therefore, it is necessary to increase government, donor prioritisation and political support in order to ensure increased investment and commitment to cervical cancer elimination in Nigeria.PMID:36168955 | DOI:10.1177/10732748221130180
Source: Cancer Control - September 28, 2022 Category: Cancer & Oncology Authors: Yetunde O John-Akinola Chizoma M Ndikom Mojisola M Oluwasanu Temitayo Adebisi Oluwaponmile Odukoya Source Type: research

Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening
CONCLUSIONS: The study shows that currently available prophylactic vaccines have the potential to be useful in the primary prevention of HPV infections in the country. This study strengthens the belief that prophylactic HPV vaccination could be a long-term strategy to reduce the burden of HPV infections and potentially reduce the burden of HPV-associated cancers and epithelial cell abnormalities among health-seeking women in Kumasi. Efforts to make vaccines available to young girls should be prioritized.PMID:35536890 | DOI:10.1177/10732748221094721
Source: Cancer Control - May 10, 2022 Category: Cancer & Oncology Authors: Emmanuel T Donkoh Richard H Asmah Francis Agyemang-Yeboah Ellis O Dabo Edwin K Wiredu Source Type: research

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta ‐analysis
ConclusionsHPV vaccination post-treatment was associated with a significantly reduced risk of CIN2+ recurrence when using unadjusted estimates from observational studies and RCTs. We found no significant effect of HPV vaccination on risk of CIN2+ recurrence when using the outcome measure from observational studies with the least risk of bias. Large, well-designed randomized placebo-controlled trials are needed to determine whether post-treatment HPV vaccination should be recommended to all women undergoing excisional treatment for CIN.
Source: Acta Obstetricia et Gynecologica Scandinavica - April 26, 2022 Category: OBGYN Authors: Dina Overgaard Eriksen, Pernille Tine Jensen, Jeppe Bennekou Schroll, Anne Hammer Tags: SYSTEMATIC REVIEW Source Type: research

Mapping sociodemographic and geographical differences in human papillomavirus non-vaccination among young girls in Sweden
CONCLUSIONS: Our findings underscore the importance of universal yet tailored approaches, including providing adequate information about HPV vaccination in Swedish and other languages, and of health-care professionals displaying sensitivity to patients' and parents' questions or needs.PMID:35120427 | DOI:10.1177/14034948221075410
Source: Scandinavian Journal of Public Health - February 5, 2022 Category: International Medicine & Public Health Authors: Maria Wemrell Raquel Perez Vicente Juan Merlo Source Type: research

Diagnosis and Therapy of Anal Carcinoma
Praxis (Bern 1994). 2022 Feb;110(2):89-96. doi: 10.1024/1661-8157/a003804.ABSTRACTDiagnosis and Therapy of Anal Carcinoma Summary. The squamous cell carcinoma of the anorectum is rare and subdivided into perianal, anal canal and combined carcinomas. Persistent infection with a high-risk human papillomavirus (HPV) is believed to be the main cause for the development of anal cancer. Therefore, the incidence in high-risk individuals (e.g. immuno-compromised patients or patients living with HIV) is much higher than in the general population. Nevertheless, a nearly three-fold overall increase was observed within the last three ...
Source: Praxis - February 2, 2022 Category: General Medicine Authors: Alexander Radke J örg Beyer Source Type: research